MHRA Class 2 Medicines Recall: Trimethoprim 200mg tablets (Ennogen)

MHRA Class 2 Medicines Recall: Trimethoprim 200mg tablets (Ennogen)

April 22, 2021

Class 2 Medicines recall: Trimethoprim 200mg tablets (Ennogen)

Drug alert number: EL (21) A/10

Date issued: 22nd April 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 medicines recall for:

Trimethoprim 200mg tablets (Ennogen) PL 40147/0083

Ennogen Pharma Limited are recalling an affected batch of Trimethoprim 200mg Tablets as a precautionary measure due to the observation of a foreign tablet, which is identified as Trimethoprim 100mg Tablet.

 

Batch Number Expiry Date Pack Size First Distributed
1403288 30/09/2023 14 21/01/2021

Advice for healthcare professionals

  • Stop supplying the batches listed above immediately.
  • Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Full drug alert can be viewed here.

Company contacts for further information

For more information or medical information queries, please contact Ennogen QA at qagenerics@ennogen.com.

For stock control queries, please contact Alex Durall and Claire Willey on alex@ennogen.com and claire@ennogen.com.

 



Posted in:


More Latest News >

PQS: AMS virtual event now on-demand

Community pharmacy contractors can now access an online recording of the antimicrobial stewardship (AMS) virtual event, which was jointly hosted...

Evaluation of LFD tests

As part of meeting Medicines and Healthcare products Regulatory Agency (MHRA) obligations, the UK Health Security Agency (UKHSA) – of...